Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Susceptible Pulmonary Tuberculosis”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Looking for participantsNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Testing effectiveness (Phase 2)UnknownNCT04768231
What this trial is testing

Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

Who this might be right for
Tuberculosis
Hospital Universitari Vall d'Hebron Research Institute 130
Not applicableStudy completedNCT00834353
What this trial is testing

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Who this might be right for
Pulmonary Tuberculosis
Maulana Azad Medical College
Not applicableNot Yet RecruitingNCT07387601
What this trial is testing

Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia

Who this might be right for
to Assess Effect of Peer-led Education
Bahirdar University 250
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129629
What this trial is testing

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryDrug-Susceptible Pulmonary Tuberculosis
Shanghai Pulmonary Hospital, Shanghai, China 45
Testing effectiveness (Phase 2)Study completedNCT05455112
What this trial is testing

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Archivel Farma S.L. 41
Large-scale testing (Phase 3)Study completedNCT00130247
What this trial is testing

Tuberculosis Treatment Shortening Trial

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 394
Large-scale testing (Phase 3)Active Not RecruitingNCT04856644
What this trial is testing

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Kaohsiung Veterans General Hospital. 333
Testing effectiveness (Phase 2)Study completedNCT05221502
What this trial is testing

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

Who this might be right for
Pulmonary TB
Otsuka Pharmaceutical Development & Commercialization, Inc. 122
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Testing effectiveness (Phase 2)Temporarily pausedNCT04694586
What this trial is testing

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Who this might be right for
Tuberculosis, Pulmonary
University Hospital, Linkoeping 40
Testing effectiveness (Phase 2)Looking for participantsNCT06748937
What this trial is testing

The Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Who this might be right for
Tuberculosis
TASK Applied Science 60
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 127
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 77
Not applicableUnknownNCT04264221
What this trial is testing

Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging

Who this might be right for
Pulmonary TB
Farman Ullah Khan 600
Post-approval studies (Phase 4)UnknownNCT02901288
What this trial is testing

Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Beijing Chest Hospital 3,900
Early research (Phase 1)Study completedNCT02375698
What this trial is testing

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB

Who this might be right for
Tuberculosis
Aeras 22
Load More Results